0RIS

Noticias Targovax Asa

Las mejores ofertas para acceder a los datos en tiempo real!
Real-time Level 1 for London Stock Exchange
Suscripción Mensual
Por sólo
US$29.56
Real-time Level 2 for London Stock Exchange
Suscripción Mensual
Por sólo
US$77.61
Real-time London Stock Exchange & FTSE
Suscripción Mensual
Por sólo
US$88.69
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Targovax Asa 0RIS London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.0% 15.98 18:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.98
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/11/202101:35PRNUSTargovax ASA: Third quarter 2021 results
04/11/202101:28PRNUSTargovax ASA: Third quarter 2021 results
25/10/202106:48PRNUSTargovax: Presentation material for today's webcast
25/10/202106:47PRNUSTargovax: Presentation material for today's webcast
20/10/202101:50PRNUSTargovax ASA appoints Dr. Erik Digman Wiklund as new CEO
20/10/202101:48PRNUSTargovax ASA appoints Dr. Erik Digman Wiklund as new CEO
19/10/202107:27PRNUSTargovax to present at upcoming conferences
19/10/202107:24PRNUSTargovax to present at upcoming conferences
06/10/202108:00PRNUSTargovax ASA: Two abstracts accepted at the SITC Congress
06/10/202107:51PRNUSTargovax ASA: Two abstracts accepted at the SITC Congress
30/9/202100:49PRNUSTargovax ASA appoints Ola Melin as Head of Manufacturing
30/9/202100:42PRNUSTargovax ASA appoints Ola Melin as Head of Manufacturing
24/9/202104:19PRNUSTargovax granted European Patent for ONCOS-102 in..
24/9/202104:17PRNUSTargovax granted European Patent for ONCOS-102 in..
16/9/202100:42PRNUSTargovax ASA: Poster at European Society for Medical..
16/9/202100:41PRNUSTargovax ASA: Poster at European Society for Medical..
27/8/202102:17PRNUSTargovax ASA: Abstract on ONCOS-102 phase 1 trial in..
27/8/202102:15PRNUSTargovax ASA: Abstract on ONCOS-102 phase 1 trial in..
18/8/202100:57PRNUSTargovax ASA: second quarter and first half year 2021..
18/8/202100:55PRNUSTargovax ASA: second quarter and first half year 2021..
16/8/202100:48PRNUSTargovax to present at upcoming scientific conferences
09/8/202100:14PRNUSTargovax ASA: Invitation to presentation of Targovax's..
09/8/202100:13PRNUSTargovax ASA: Invitation to presentation of Targovax's..
01/7/202104:11PRNUSTargovax ASA appoints Dr Lone Ottesen as Chief Development..
01/7/202104:10PRNUSTargovax ASA appoints Dr Lone Ottesen as Chief Development..
28/6/202100:43PRNUSTargovax to present at the 4th Annual Next Gen..
28/6/202100:34PRNUSTargovax to present at the 4th Annual Next Gen..
10/6/202106:44PRNUSTargovax's ONCOS-102 mesothelioma 24-month data shows..
10/6/202106:42PRNUSTargovax's ONCOS-102 mesothelioma 24-month data shows..
21/5/202100:21PRNUSTargovax to present at upcoming investor and scientific..
21/5/202100:19PRNUSTargovax to present at upcoming investor and scientific..
06/5/202100:20PRNUSTargovax ASA: First quarter 2021 results
06/5/202100:18PRNUSTargovax ASA: First quarter 2021 results
04/3/202109:47PRNUSTargovax ASA: Registration of share capital increase..
04/3/202109:45PRNUSTargovax ASA: Registration of share capital increase..
01/3/202111:26PRNUSTargovax ASA: Exercise of options under LTI program and..
01/3/202111:24PRNUSTargovax ASA: Exercise of options under LTI program and..
23/2/202100:16PRNUSContinued survival benefit in Targovax's ONCOS-102 trial in..
18/2/202100:43PRNUSReminder: Invitation to Targovax's Capital Markets Day 18..
18/2/202100:39PRNUSReminder: Invitation to Targovax's Capital Markets Day 18..
15/2/202100:17PRNUSTargovax receives Fast-Track designation for ONCOS-102
15/2/202100:15PRNUSTargovax receives Fast-Track designation for ONCOS-102
11/2/202100:44PRNUSAgenda for Targovax's Capital Markets Day 18 February 2021
11/2/202100:42PRNUSAgenda for Targovax's Capital Markets Day 18 February 2021
10/2/202100:22PRNUSTargovax and Papyrus Therapeutics enter research..
10/2/202100:18PRNUSTargovax and Papyrus Therapeutics enter research..
06/1/202100:18PRNUSTargovax grants IOVaxis 3 months extension to the exclusive..
06/1/202100:15PRNUSTargovax grants IOVaxis 3 months extension to the exclusive..
15/12/202000:31PRNUSTargovax ASA: Save the date - Capital Markets Day 2021
15/12/202000:30PRNUSTargovax ASA: Save the date - Capital Markets Day 2021
Ver más noticias sobre esta acción »
Su Consulta Reciente
LSE
0RIS
Targovax A..
Regístrese ahora para ver estas acciones en su Monitor streaming ADVFN.

Usted puede agregar y ver hasta 110 símbolos de sus acciones favoritas al mismo tiempo y completamente gratis.

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V: D:20211203 08:13:32